IM21.7c serves as a cationic lipid used in lipid nanoparticles (LNPs) for mRNA delivery. LNPs containing IM21.7c selectively accumulate in the lungs and spleen, enhancing targeted in vivo delivery after intravenous administration.
Usually ships within 24 hours.